Evidence map›Paper›PMID 42893186›Full record

ArticleAmerican journal of preventive cardiology2027

Heart failure and atrial fibrillation prediction from non-gated chest CT scans using AI-based cardiac chamber volumetry: an AI-CVD study within the multi-ethnic study of atherosclerosis (MESA).

Seyed Reza Mirjalili, Kyle Atlas, Anthony P Reeves, Chenyu Zhang, Jakob Wasserthal, Amir Azimi, Ali Hashemi, Mohammadhossein Mozafarybazargany, Amir Ghaffari Jolfayi, Thomas Atlas and 22 more

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Seyed Reza MirjaliliHeartLung.AI, Houston, TX, 77021, USA.
Kyle AtlasHeartLung.AI, Houston, TX, 77021, USA.
Anthony P ReevesDepartment of Electrical and Computer Engineering, Cornell University, Ithaca, NY. 14853, USA.
Chenyu ZhangHeartLung.AI, Houston, TX, 77021, USA.
Jakob WasserthalClinic of Radiology and Nuclear Medicine, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.
Amir AzimiHeartLung.AI, Houston, TX, 77021, USA.
Ali HashemiHeartLung.AI, Houston, TX, 77021, USA.
Mohammadhossein MozafarybazarganyHeartLung.AI, Houston, TX, 77021, USA.
Amir Ghaffari JolfayiHeartLung.AI, Houston, TX, 77021, USA.
Thomas AtlasTustin Teleradiology, Tustin, CA 92780, USA.
Claudia I HenschkeIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
David F YankelevitzIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Javier J ZuluetaIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Wenjun FanDepartment of Epidemiology and Biostatistics, Wen School of Public Health, University of California, Irvine, USA.
Jeffrey I MechanickKravis Center for Clinical Cardiovascular Health, Mount Sinai Fuster Heart Hospital, New York, NY 10029 USA.
Andrea D BranchIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Khurram NasirHouston Methodist Hospital, Houston, TX 77030, USA.
Zahi FayadBioMedical Engineering and Imaging Institute. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Michael V McConnellStanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jamal S RanaDivision of Cardiology, Kaiser Permanente Oakland Medical Center, California, USA.
Rozemarijn VliegenthartDepartment of Radiology, University Medical Center Groningen, GZ 9713, Netherlands.
David J MaronStanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Jagat NarulaUniversity of Houston, Houston, TX, 77030, USA.
Matthew J BudoffThe Lundquist Institute, CA 90502, USA.
Roxana MehranIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Kim A WilliamsUniversity of Louisville, Louisville, KY, 40202, USA.
Prediman K ShahCedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Oren MechanicThe Agatston Center, Miami Beach, Florida, USA.
Arthur S AgatstonThe Agatston Center, Miami Beach, Florida, USA.
Robert A KlonerHuntington Medical Research Institutes, Pasadena, CA, 91105, USA and Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA.
Nathan D WongHeart Disease Prevention Program, Mary and Steve Wen Cardiovascular Division, University of California Irvine School of Medicine, CA 92697, USA.
Morteza NaghaviHeartLung.AI, Houston, TX, 77021, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We previously demonstrated that AI-derived cardiac chamber volumetry in ECG-gated CT scans predicts atrial fibrillation (AF) and heart failure (HF). Since most chest CTs are non-gated, and the American Heart Association recently highlighted their value for opportunistic cardiovascular risk assessment using AI-based coronary artery calcium scoring, we extended this concept to evaluate whether AI-derived chamber volumetry from non-gated CTs can reliably predict HF and AF.s. Methods: We compared AI-derived chamber volumetry from non-gated and ECG-gated chest CTs in 2053 Multi-Ethnic Study of Atherosclerosis (MESA) Exam 5 participants using mean and standard-deviation of absolute differences, intraclass correlation coefficients (ICC), and Cohen's κ. Variability between paired ECG-gated scans was determined by analyzing scans acquired 2 min apart in 5749 MESA Exam 1 participants. Predictive performance for incident HF and AF was compared using cumulative incidence curves, age- and sex-adjusted C-indices, and non-inferiority testing (δ=0.05). Results: Non-gated scans demonstrated excellent overall agreement with ECG-gated scans, with comparable performance for detecting cardiac chamber enlargement (98.8-99.2%, κ=0.76-0.84), relative to agreement observed between paired ECG-gated scans (98.6-98.9%, κ=0.72-0.77). Cumulative incidence curves for HF and AF stratified by quartiles showed substantial overlap. Age- and sex-adjusted C-indices were comparable for left atrial volume (0.75 vs 0.74, Conclusion: AI-based evaluation of non-gated chest CT may provide reliable cardiac chamber volumetry and cardiovascular outcome prediction, enabling opportunistic screening for HF and AF risk.

Indexed as

Artificial intelligenceAtriumCardiovascular diseaseComputed tomographyVentricle

Identifiers

PMID42893186
PMCPMC13676062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.